» Articles » PMID: 37331780

The Promise and Future of Radiomics for Personalized Radiotherapy Dosing and Adaptation

Overview
Specialties Oncology
Radiology
Date 2023 Jun 18
PMID 37331780
Authors
Affiliations
Soon will be listed here.
Abstract

Quantitative image analysis, also known as radiomics, aims to analyze large-scale quantitative features extracted from acquired medical images using hand-crafted or machine-engineered feature extraction approaches. Radiomics has great potential for a variety of clinical applications in radiation oncology, an image-rich treatment modality that utilizes computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) for treatment planning, dose calculation, and image guidance. A promising application of radiomics is in predicting treatment outcomes after radiotherapy such as local control and treatment-related toxicity using features extracted from pretreatment and on-treatment images. Based on these individualized predictions of treatment outcomes, radiotherapy dose can be sculpted to meet the specific needs and preferences of each patient. Radiomics can aid in tumor characterization for personalized targeting, especially for identifying high-risk regions within a tumor that cannot be easily discerned based on size or intensity alone. Radiomics-based treatment response prediction can aid in developing personalized fractionation and dose adjustments. In order to make radiomics models more applicable across different institutions with varying scanners and patient populations, further efforts are needed to harmonize and standardize the acquisition protocols by minimizing uncertainties within the imaging data.

Citing Articles

Prognostic significance of the mEPE score in intermediate-risk prostate cancer patients undergoing ultrahypofractionated robotic SBRT.

Mose L, Loebelenz L, Althaus A, Ahmadsei M, Mathier E, Broemel I Strahlenther Onkol. 2025; .

PMID: 39809998 DOI: 10.1007/s00066-024-02355-y.


Application of CT-based foundational artificial intelligence and radiomics models for prediction of survival for lung cancer patients treated on the NRG/RTOG 0617 clinical trial.

Upadhaya T, Chetty I, McKenzie E, Bagher-Ebadian H, Atkins K BJR Open. 2024; 6(1):tzae038.

PMID: 39568594 PMC: 11576354. DOI: 10.1093/bjro/tzae038.


"Under the hood": artificial intelligence in personalized radiotherapy.

Gianoli C, De Bernardi E, Parodi K BJR Open. 2024; 6(1):tzae017.

PMID: 39104573 PMC: 11299549. DOI: 10.1093/bjro/tzae017.


A Historical Survey of Key Epidemiological Studies of Ionizing Radiation Exposure.

Little M, Bazyka D, Berrington de Gonzalez A, Brenner A, Chumak V, Cullings H Radiat Res. 2024; 202(2):432-487.

PMID: 39021204 PMC: 11316622. DOI: 10.1667/RADE-24-00021.1.

References
1.
van Timmeren J, Cester D, Tanadini-Lang S, Alkadhi H, Baessler B . Radiomics in medical imaging-"how-to" guide and critical reflection. Insights Imaging. 2020; 11(1):91. PMC: 7423816. DOI: 10.1186/s13244-020-00887-2. View

2.
Foy J, Robinson K, Li H, Giger M, Al-Hallaq H, Armato 3rd S . Variation in algorithm implementation across radiomics software. J Med Imaging (Bellingham). 2019; 5(4):044505. PMC: 6278846. DOI: 10.1117/1.JMI.5.4.044505. View

3.
Gillies R, Kinahan P, Hricak H . Radiomics: Images Are More than Pictures, They Are Data. Radiology. 2015; 278(2):563-77. PMC: 4734157. DOI: 10.1148/radiol.2015151169. View

4.
Wang K, Zhou Z, Wang R, Chen L, Zhang Q, Sher D . A multi-objective radiomics model for the prediction of locoregional recurrence in head and neck squamous cell cancer. Med Phys. 2020; 47(10):5392-5400. DOI: 10.1002/mp.14388. View

5.
Nasief H, Hall W, Zheng C, Tsai S, Wang L, Erickson B . Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9. Front Oncol. 2020; 9:1464. PMC: 6960122. DOI: 10.3389/fonc.2019.01464. View